Skip to main content

CITADEL ADVISORS LLC

Position in TPST — Tempest Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in TPST

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$22,000
+$22,000 QoQ
Shares Held
19,820
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 21 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TPST Over Time

Shares Held

Position Value (USD)

Derivatives in TPST

reported options exposure · as of Mar 31, 2025
CallValue
$20,959
CallShares
2,185
PutValue
$13,948
PutShares
1,454

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,151,065,112 across 436 Biotechnology names. TPST ranks #413 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TPST

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,000 19,820
2025-03-31 $20,959 28,400
2025-03-31 $13,948 18,900
2024-12-31 $28,807 34,500
2024-12-31 $53,439 64,000
2024-09-30 $76,439 54,600
2024-09-30 $38,499 27,500
2024-06-30 $176,294 80,500
2024-06-30 $64,823 29,600
2024-06-30 $201,988 92,232
2024-03-31 $11 3
2024-03-31 $52,784 13,500
2024-03-31 $304,979 78,000
2023-12-31 $2,639 600
2023-12-31 $249,479 56,700
2023-09-30 $13,689 44,882